Simon Benito
Chairman at INOVIO PHARMACEUTICALS, INC.
Net worth: 109 083 $ as of 2024-03-30
Profile
Simon X.
Benito is currently the Chairman at Inovio Pharmaceuticals, Inc. He previously held positions as a Director at Genetronics Biomedical Corp., an Independent Director at DURECT Corp., and as an Executive Director & Vice President at Merck Human Health US.
He also served as the Senior Vice President-Vaccine Division at Merck & Co., Inc. and as the Executive Vice President-Medco Managed Care at Merck-Medco Managed Care LLC.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-11-15 | 7,859 ( 0.03% ) | 109 083 $ | 2024-03-30 |
Simon Benito active positions
Companies | Position | Start |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Chairman | 2019-01-02 |
Former positions of Simon Benito
Companies | Position | End |
---|---|---|
DURECT CORPORATION | Director/Board Member | 2022-06-14 |
Genetronics Biomedical Corp. | Director/Board Member | 2005-04-04 |
MERCK & CO., INC. | Corporate Officer/Principal | 1998-12-31 |
Merck-Medco Managed Care LLC
Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck-Medco Managed Care LLC discovers, develops, and markets a broad range of human and animal health products. The private company is based in Whitehouse Station, NJ. | Corporate Officer/Principal | 1995-12-31 |
Merck Human Health US | Director/Board Member | 1992-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
DURECT CORPORATION | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Genetronics Biomedical Corp. | Commercial Services |
Merck-Medco Managed Care LLC
Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck-Medco Managed Care LLC discovers, develops, and markets a broad range of human and animal health products. The private company is based in Whitehouse Station, NJ. | Health Technology |
Merck Human Health US |
- Stock Market
- Insiders
- Simon Benito